Pfizer buys Seagen for $43B, boosts access to cancer drugs - Terrace Standard

France Nouvelles Nouvelles

Pfizer buys Seagen for $43B, boosts access to cancer drugs - Terrace Standard
France Dernières Nouvelles,France Actualités
  • 📰 TerraceStandard
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 68%

Pfizer buys Seagen for $43B, boosts access to cancer drugs

The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug developer “continue innovating,” except with more resources than it would have alone, Pfizer Chairman and CEO Albert Bourla told analysts.

Cancer treatments are a priority for Pfizer. They brought in $12 billion in revenue for the drugmaker last year. But Pfizer has only marketed a couple first-generation ADC treatments, a spokeswoman said. Seagen’s top seller, Adcetris, treats lymph system cancers. It brought in $839 million in sales last year, a 19% increase over the previous year.

Bourla said earlier this year that the company planned to use its “extraordinary firepower” to buy products that will deliver $25 billion in incremental revenue by 2030.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

TerraceStandard /  🏆 24. in CA

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Pfizer buys Seagen for $43B, boosts access to cancer drugsPfizer buys Seagen for $43B, boosts access to cancer drugsPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Lire la suite »

Pfizer buys Seagen for US$43B, boosts access to cancer drugsPfizer buys Seagen for US$43B, boosts access to cancer drugsPfizer is spending about US$43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Lire la suite »

Pfizer to buy cancer drugmaker Seagen in US$43B deal - National | Globalnews.caPfizer to buy cancer drugmaker Seagen in US$43B deal - National | Globalnews.caPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumour cells while sparing surrounding healthy tissue.
Lire la suite »

Pfizer buys Seagen for $43-billion, boosts access to cancer drugsPfizer buys Seagen for $43-billion, boosts access to cancer drugsThe deal will combine Seagen’s technology with Pfizer’s scale and strength, Pfizer CEO Albert Bourla says in a statement
Lire la suite »

Pfizer buys Seagen for $43 Billion, boosts access to cancer drugsPfizer buys Seagen for $43 Billion, boosts access to cancer drugsPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Lire la suite »

Break-ins plague Terrace and area business community - Terrace StandardBreak-ins plague Terrace and area business community - Terrace StandardBreak ins plague TerraceBC and area business community
Lire la suite »



Render Time: 2025-03-26 01:29:37